Oncology Pathways Engagement

Oncology Pathways Engagement provides insights on the evolution of oncology pathways, supporting timely, effective engagement with each stakeholder type to optimize access for branded oncology drugs.

  • What are the current and projected implementation levels of oncology pathways by cancer type?

  • Which stakeholders have the greatest influence on oncology pathway development?

  • What are the key features of the trade-off analysis that oncologists use to choose between plan-, system-, and group-developed pathways?

  • Where do individual health plans and organized providers fall on the continuum of oncology pathway implementation, measurement, and adherence?

  • What are the best opportunities to increase brand inclusion in oncology pathways?

Use Oncology Pathways Engagement to:

  • Assess current levels of oncology pathway implementation, measurement, and adherence
  • Gain in-depth understanding of impact of oncology pathways and factors promoting their continued use by stakeholders
  • Identify customer engagement strategies that effectively promote inclusion of brands in oncology pathways
  • Oncology Pathway Landscape April
    • Health plan, organized provider, oncologist, and pathway vendor role and influence in oncology pathway development, participation, and adherence
    • Assessment of oncologist pathway adoption at point of care, including rationales (e.g., financial incentives) for choosing plan, group, or system pathways
  • Health Plan Segmentation and Profiles May
    • Framework identifying individual health plan placement on the continuum of pathway implementation, measurement, and adherence, with connection tree comprising key influencers in pathway development
    • Profiles of 20 health plans, including current pathway implementation and key attributes by cancer type
  • Organized Provider Segmentation and Profiles June
    • Framework identifying individual organized provider placement on the continuum of pathway implementation, measurement, and adherence
    • Profiles of 80 organized providers (integrated health systems and community-based oncology practices), including current pathway implementation and key attributes by cancer type
  • Engaging with Oncology Pathway Vendors September
    • Profiles of oncology pathway vendor organizations, including current offerings and level of treatment recommendation adoption by customers
    • Identification of key influencers of pathway development and assessment of opportunities for biopharmaceutical company engagement with pathway vendors
  • Additional Service Offerings
    • In-depth report and chart pack analyzing pathways landscape by specific cancer type
    • In-depth report and chart pack analyzing benchmarking and best practices in pathway-specific engagement by biopharmaceutical companies
    • Account training on customer engagement relating to oncology pathways

Interested in a product?

Contact Us